RSSDI 2003 XXXI Annual Scientific Meeting

RSSDI 2003 XXXI Annual Scientific Meeting of RSSDI was held between October 10 and 12, 2003 in Jaipur

Diabetes Update Programme

(under the aegis of the RSSDI 2003)

Birla Auditorium, Jaipur

October 10, 2003

Registration           :         8.15-8.45 AM

Welcome              :         8.45-8.55 AM:   Anant Nigam, Jaipur

Session 1              :         9.00  AM

Chair:                    :         AK Das, Pondicherry

Co-Chair               :         RK Goyal, Ajmer; S Gupta, Nagpur

9.00-9.15AM         :         Pathophysiology of Type 1 & Type 2 Diabetes : Current Understanding
                                      SV Madhu, New Delhi  

9.15-9.30AM         :         Clinical Diagnosis of Type 1 & Type 2 Diabetes

                                      DC Sharma, Udaipur

9.30-9.45AM         :         Management of women with type 2 diabetes who become Pregnant.
                                      V Balaji, Chennai


9.45-10.00 AM      :         Discussion

Session 2              :         10.00 AM

Chair                     :         S.K.Wangnoo, New Delhi

Co-Chair               :         Dr K M Surya Narayana, RP Agarwal, Bikaner;

10.00-10.15AM     :         Goals of Therapy and Monitoring Glycemic Control in Type 1 Diabetes.
          Archana Dayal Arya, New Delhi

10.15-10.30AM     :         Managing Acute Complications in Type 1 Diabetes.

                                      SK Sharma, Jaipur

10.30-10.45AM     :         Hypoglycemia in Type 1 Diabetes Therapy: Is it a barrier for Good  
          Glycemic Control? 
          R G Naik- Mumbai

                          

10.45-11.00 AM    :         Discussion

11.00-11.30 AM    :         Coffee break

Session 3              :         11.30 AM

Chair                     :         Subhankar Choudhary, Kolkatta

Co-Chair               :         S.Jindal, Bhopal; Manoj Chadha, Mumbai

11.30-11.45           :         Evaluation of cardiac function status in Type 2 diabetes.

                                       RK Tongia, Jaipur

11.45-12.00           :         Visual Impairment in Diabetes Mellitus. How fruitful is

treatment for diabetic retinopathy in the Indian scenario?  
Rema Mohan, Chennai

12.00-12.15           :         Painful Diabetic Neuropathy.. Is the treatment effective? 

                   Nikhil Tandon, New Delhi 

12.00-12.15           :         Discussion

Session 4              :         12.15 PM

Chair                     :         SM Sadikot, Mumbai  

Co-Chair               :         SK Singh, Varanasi; Jitendra Singh, Jammu

12.15-12.30           :         Initiating therapy in recently diagnosed Type 2 Diabetes..

                                      Monotherapy or Combination Therapy?

                                      Satinath Mukherjee - Kolkatta

12.30-12.45           :         Non-Glycemic Targets in Type 2 Diabetes ..
                   How aggressively should we treat them? 
                   Anil Bhansali, Chandigarh

12.45  -1.00           :         Patient Education Improves Overall Diabetes Control. Is it true?

                   Rishi Shukla, Kanpur

1.00-1.15 PM        :         Discussion

1.15- 1..30 PM      :         Closing Remarks

1.30-2.15 PM        :         LUNCH

                   

RSSDI 2003

Birla Auditorium, Jaipur

Saturday: October 11, 2003

 

 

Registration           :         8.00- 9.00 AM

SESSION 1

9.00-9.30 AM      :         Presidential oration-“ Lipids, Diabetes & CAD in Indians”
                                      Dr S Das

Chairpersons         :         Dr O P Gupta -Ahmedabad      

Prof K M Prasanna Kumar-Bangalore

 

9.30-10.00AM     :         RSSDI Oration  - Dr V Mohan, MDRF, Chennai.

                                      “Why are Indian Diabetics more prone to coronary artery disease”

Chairpersons         :         Dr B K Sahay - Hyderabad  

Dr Alok Kanungo - Cuttack

SESSION 2
10.00-11.15AM   :         M M S Ahuja Symposis - Vacular wall &Diabetes Mellitus,

Chairpersons         :         Dr H B Chandalia-Mumbai                 

Dr Om P Ganda-USA                        

10.00 – 10.15 AM         :         “Vessel wall in Diabetes  ” –

Dr Ravi Kasliwal –New Delhi

10.15 – 10.30 AM :       Evaluation of Vascular disease and its correlation

with clinical outcome in T 2 DM patients-

Aftab S.A.S, Manipal

10.30-10.45 AM  :         Coronary angiographic profile in patients of DM with CAD –
                                      Jayant K Panda – Cuttack

10.45-11.00AM-            “CCA-INT-an ideal marker for micro &
macro vascular complications in type2 diabetes ” –

Dr Sudheer Bhandari

11.15-11.30 AM  :         Discussion

11.30-11.45 AM  :         Coffee break

SESSION 3

11.45-12.45 PM   :         Theme topic-Nutrition counseling Strategies in India                                                                                                                                                                                                                                      

Chairpersons         :         1) S S Rastogi- New Delhi        

2) Mrs. Rekha Sharma AIIMS

11.45 –12.00 PM  :       Opening remarks & nutritional strategies-

Mrs. Rekha Sharma     AIIMS

12.00-12.45 PM   :        Nutritional strategies in Diabetes-

1)  Low fat & high Fiber diet in Type 2 Diabetes-

Mrs Lakshmi- Bangalore

2)     Oxidative changes in fats by various Indian cooking practices – Priyanka Rastogi – Jaipur

3)     Medical nutrition therapy in Diabetes-“Strategies for compliance”-
H B Chandalia – Mumbai

                                      4)  Impact of High protein diet on Micro- Albuminuria

                        in Insulin Dependent Diabetes Mellitus (Type 1) Children –
                        Dr Rekha V Bhat – Bangalore  

12.45 - 1.00PM   :         DISCUSSION

1.00-2.00              :         LUNCH

                   

SESSION 4

2.00PM-3.30PM                               :           Diabetes in children/adolescent

Chairpersons         :         Dr Sam G P Moses-Chennai    

Dr Suresh C Purohit-Mumbai

                                       Dr Siddarth Shah- Mumbai

                                       Data from Bangalore       -        Dr Geetha Bhat

 Data from Vizag             -        Dr G R Sridhar

 Data from Mumbai         -        Dr Dhruv Singh

                                        Data from Jaipur            -        Dr Anant Nigam

                                        Data From Erode                    -        Dr Bhavatharini


 3.30-4.15 PM       :         Clinical research-Indian experience-

Multicentric Studies

Chairpersons       :        Dr V Seshiah -Chennai           
Dr K J Shetty -Nepal 

CINDI                            -        Dr S R Aravind

Dr Sarita Bajaj  

GDM in India                  -        Dr Madhuri Balaji

High Prevalence of GDM-         Dr Kale

DNA Human insulin-

Indian experience – Regular –    Dr Pendsey S,

Biphasic                          -        Dr H B Chandalia

NPH                               -        Dr M Badgandi

4.15 - 430PM       :         TEA BREAK

4.30 – 5.00PM       :      Dr Michael Engelgau, MD-Austin- USA - Translating

clinical Research to practice

Chairperson             :      Dr Satish K Agarwal- New Delhi  

Dr N R Rao   - Manipal             

RSSDI 2003

Birla Auditorium, Jaipur

SUNDAY-October 12, 2003

 

SESSION 1

9.00-9.30 AM                :         Sam G P Moses Oration

Dr D K Hazra  “ Diabetes prevention is it achievable?”

Chairpersons                            Dr B B Tripathy – Bhuvaneshwar , Dr A C Ammini – New Delhi

SESSION 2

9.30-11.00 AM              :         12-Free Papers - Oral presentation

7 minutes presentation             

Chairpersons                   :         Dr R V Jaya Kumar-Kottayam  

Dr P V Rao-Hyderabad

                                                1 Diabetes Prevention Programme-BARSI

Experience

                                                          Dr Sanjay Sirdeshpande       

2 Metabolic Syndrome in a Kerala Population

V Usha Menon

3 Reversal of Diabetes By Allotransplantation of Rats Pancreatic Islets – An Ultrastructural Study

          S Gunasekaran

4 Comparative efficacy of Metformin and pioglitazone in Reducing C-Reactive Protein in Type –2 Diabetes mellitus

B S Bal

5 Effect of Hormone Replacement Therapy on Insulin Sensitivity in Non White Post Menopausal Women -
          Pinaki Dutta

6 Prevalence of Diabetic Retinopathy and influencing factors amongst Type 2 Diabetics from Central India.

          Sunil Gupta.

7 Effect of Type 2 Diabetes Mellitus on the Bone Mineral Density of Postmenopausal Women.

          Rashmi A Purohit - Bangalore

                                                8. Triglyceride levels and its correlation with

                                                carotid intima-media thickness –

                                                          Neetha Deshpande - Belgaum.

                                                  

 

SESSION 3

11.00-11.30AM             :         Prof Vishwanathan memorial Oration

Dr Om P Ganda “Reflections on Diabetes Research during The past three decades”

Chairpersons                   :         Dr C Munichoodappa-Bangalore        

Dr Anant Nigam -Jaipur

11.30-11.45                    :         Coffee break

SESSION 4

11.45-12.15 PM            :         Guest Lecture - DR David  Price-USA:
"The Role of SMBG in Type II Diabetes"

Chairpersons                   :         Dr K Kannan-Madhurai            

Dr N Sudhakar Rao-Hyderabad

SESSION 5

12.15-1.15 PM                 :      Short research presentations-

7 minutes with 12 slides- 3 minutes discussion

Chairpersons                   :         Dr Padma S Menon -Mumbai   

Dr Muralidhar S Rao-Gulbarga

1) Fasting glucose and CVD risk factors in an urban Indian 
    population-Dr Rajeev Gupta

2) Comparison of Insulin Secretion and Insulin Resistance in Type 2  
    Diabetes in Children and in Young Adults. C Snehalatha

3) Metabolic syndrome and Diabetic CAD

    Dr Vijay Achari

4) rDNA  Human Insulin - Unique manufacturing technology,-
    M K Sahib,

                           

1.15PM -1.30PM          :        VOTE OF THANKS

1.30PM-2.30PM           :        LUNCH


RSSDI 2003 Secretariat

Dr. Anant Nigam
Organising Chairman
A-46 BAJAJ NAGAR
Jaipur 302 015 RJ
tel 0141 2705303 2706303
fax 2510601
dranigam@hotmail.com 		Dr. Arvind Gupta
Organising Secretary
D-88 Krishna Marg, Bapu Nagar
Jaipur 302 015 RJ
tel 0141 2708808
fax 2214796
arvindneelam@hotmail.com

Last date for early Registration : 15th June 2003
Last date for Abstracts : 30th August 2003

RSSDI-2003-Jaipur

ABSTRACTS - FREE PAPERS
(5 minutes 7 slides presentation)
Original communication is invited on any subject relevant to understanding of diabetes and care of diabetics. Abstracts must be based on results that have not been published in any journal before October 2003. Abstract should be within 250 words. It is mandatory that the presenting author of any abstract accepted for presentation attends RSSDI 2003 at Jaipur to present his/her paper.

Diabetes in Indian children
(7 minutes 15 slides presentation)
Abstracts on childhhood diabetes in India are invited.
The study should have minimum of 100 children preferably including any of the following data :
Type of Diabetes - Type 1, Type 2, genetic syndromes, secondary and others, age of onset, sex distribution, economics, complications, treatment, mortality, rural vs urban, growth, bone density, puberty, DKA, psychosocial aspects, antibody status, other associated autoimmune disease.
(submit whatever data is available. Not all data may be available for all patients. Indicate the number of patients for each variable)

Multicentric clinical research in Diabetes- Indian experience
(10 minutes-2 investigators presentation-5 minutes discussion)
Abstracts are invited from clinical research diabetologists on multicentric clinical research conducted in India regarding epidemiology, treatment, complications, drug trial, insulin devices, economics and monitoring glycaemic control.

THEME SUBJECTS

Nutrition Section : Nutritional strategies in Diabetes
Scientific Section : Ahuja Symposium : Vascular wall in Diabetes

Vascular wall in Diabetes : Covering risk factor analysis, peripheral vascular disease, CAD and Cerebro vascular disease Reactive oxygen species, Nitric oxide Superoxide dismutase, Homocysteine, Carotid intimal medical thickness, Microalbuminuria - intervention.
(Submit whatever data is available. Not all data may be available for all patients. Indicate the number of patients for each variable)
 

PROFORMA :
Vessel wall in diabetes mellitus
______________________________________________________

Centre:
__________________________ ______________________________________________________

Total number of evaluable patients:

(1) Physical exercise:              Yes (no:   ) / No (no:    )

(2) Smoking:                          Current (no  ) / Previous (no    )/ Never (no    )

(3) Body mass index:             <25 (no    ) / >25 (no   )

(4) Blood pressure:                <130/80 (n    ) / SBP<130 and DBP>80 (n    ) /  
SBP>130 and DBP<80 (n   ) / >130/80

(5) LDL cholesterol:               <100 mg/dl (n    ) / 100-129 (n     )/>130 (n    )

(6) HDL cholesterol:              <40 mg/dl (n    ) / 40 mg/dl and above (n    )

(7) Triglycerides:                    <150 mg/dl (n    ) / 150 mg/dl and above (n    )

(8) HbA1c:                            <7% (n    ) / 7% and above (n    )

(9) Pl glucose:                        FPG<126 and PPG<140 (n    ) / FPG<126 and PPG>140 (n   ) /
FPG>126 and PPG <126) / Both FPG>126 and PPG>140 /
Only FPG done (n   ) / Only PPG done (n)

Minimum data from 500 patients; may be retrospective or prospective.
Submit whatever data is available. Not all data may be available for all patients.
Indicate the number of patients for each variable.

Conventional risk factors like -Dyslipidemia, blood pressure, smoking, and family history,
 Non conventional risk factors like
1)            Increased fibrinogen,
2)            Infection, and inflammation
3)            Carotid artery Intima-media thickening
4)            Homocysteine
5)            Superoxide dismutase,
6)            Nitric oxide,
7)            Microalbuminuria

may be measured in smaller number of patients. They may be cross sectional or longitudinal.

 

 

NUTRITIONAL STRATEGIES FOR DIABETICS (Type – II)


Name__________________                                       Age:____(Yrs)

Sex: M ___ F___                                                         Phone Number:_______________

Address:________________________________________________________________

Ht (cms): _____       Wt (kgs):_____       IBW:______ Kgs      BMI:__________ kg/m2                    

Overweight/Obese/Normal                               Period of diabetes:____________________

Drug                             Dose                Insulin               OHAs

Medications      (a):

                         (b):

           
Comparative Study of Diabetics on High fiber (35-40g/day)

and Low fat(15g/day)diets :

 

0

4 weeks

8 weeks

12 weeks

Date

Visit I

Visit II

Visit III

Visit IV

FBS

PPBS

HbA1c

T.CHOLESTEROL

T.TRIGLYCERIDES

HDL

LDL

VLDL

WT(kgs)

FIBER INTAKE(g)

NON VEG INTAKE(g)

FAT INTAKE(g)

Vegetarian /    / Non-vegetarian

Non-Veg intake:

(a) Daily/Twice a week/Weekly/Monthly                          

(b) ______________gms/week

(c) Type of food consumed: -    Fish/Chicken/Lean meat/Organ meats/Others
 

Fiber Intake:        ________________ gms/day.